Andrew Aschenbrenner · Lawrence, Kansas
Dr. Andrew Aschenbrenner's lab focuses on improving cognitive monitoring for patients undergoing treatment for Alzheimer's disease. The team is developing a smartphone-based system to detect cognitive changes that may occur due to treatment side effects, specifically amyloid-related imaging abnormalities. This project aims to make cognitive assessments more accessible and less burdensome for patients, ultimately enhancing treatment safety and effectiveness.
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.